Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials.

Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials. Eur J Cancer. 2020 09; 136:176-185.

View in: PubMed

subject areas

Biomarkers
Clinical Trials, Phase III as Topic
Comparative Effectiveness Research
Equivalence Trials as Topic
Humans
Neoplasm Metastasis
Neoplasms
Predictive Value of Tests
Prognosis
Randomized Controlled Trials as Topic
Research Design
Survival Analysis
Treatment Outcome

authors with profiles

ADAM S GARDEN
PRAJNAN DAS
VIVEK SUBBIAH
BRUCE MINSKY
ISHWARIA MOHAN SUBBIAH